SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?


To: hoops who wrote (7996)6/28/1999 11:30:00 AM
From: American Spirit  Read Replies (1) | Respond to of 9523
 
Take all advice with a grain of salt. None of us have control over this sometimes irrational market. BKS was the first IPO backdoor which didn't go up prior to IPO date. Go figure. It ended IPO backdoor plays. Maybe someone on Wall Street intentionally skewered that. It also came out at the heat of the net crash. Couldn't have been worse timing. - PFE is a different story. Big pharmas as longterm hold blue chips. Unusual that they should get hit so hard especially as PFE has, but the market changes and patterns change.
Bet with your brain and your gut. PFE should continue to do very well. The split is bullish. It has been knocked down 30% which more than prices in any doubts the market has. Therefore I consider it a short and longterm buy. Not going to double your money but why not 10-20%?